1-6 of 6
Judith V.M.G. Bovée
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Zoledronic Acid Add-on Therapy for Standard-Risk Ewing Sarcoma Patients in the Ewing 2008R1 Trial

Raphael Koch, Lianne Haveman, Ruth Ladenstein, Benedicte Brichard, Heribert Jürgens, Sona Cyprova, Henk van den Berg, Wolf Hassenpflug, Anna Raciborska, Torben Ek, Daniel Baumhoer, Gerlinde Egerer, Leo Kager, Marleen Renard, Peter Hauser, Stefan Burdach, Judith V.M.G. Bovee, Angela M. Hong, Peter Reichardt, Jarmila Kruseova, Arne Streitbürger, Thomas Kühne, Torsten Kessler, Marie Bernkopf, Trude Butterfaß-Bahloul, Catharina Dhooge, Sebastian Bauer, János Kiss, Michael Paulussen, Fiona Bonar, Andreas Ranft, Beate Timmermann, Jelena Rascon, Volker Vieth, Jukka Kanerva, Andreas Faldum, Wolfgang Hartmann, Lars Hjorth, Vivek A. Bhadri, Markus Metzler, Hans Gelderblom, Uta Dirksen
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (24): 5057–5068.
https://doi.org/10.1158/1078-0432.CCR-23-1966
Published: 15 December 2023
View article titled, Zoledronic Acid Add-on Therapy for Standard-Risk Ewing Sarcoma Patients in the Ewing 2008R1 Trial
Open the PDF for Zoledronic Acid Add-on Therapy for Standard-Risk Ewing Sarcoma Patients in the Ewing 2008R1 Trial in another window
Includes: Supplementary data
Journal Articles

Interactions in CSF1-Driven Tenosynovial Giant Cell Tumors

David G.P. van IJzendoorn, Magdalena Matusiak, Gregory W. Charville, Geert Spierenburg, Sushama Varma, Deana R.C. Colburg, Michiel A.J. van de Sande, Kirsten van Langevelde, David G. Mohler, Kristen N. Ganjoo, Nam Q. Bui, Raffi S. Avedian, Judith V.M.G. Bovée, Robert Steffner, Robert B. West, Matt van de Rijn
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (22): 4934–4946.
https://doi.org/10.1158/1078-0432.CCR-22-1898
Published: 14 November 2022
View article titled, Interactions in CSF1-Driven Tenosynovial Giant Cell Tumors
Open the PDF for Interactions in CSF1-Driven Tenosynovial Giant Cell Tumors in another window
Includes: Supplementary data
Journal Articles

Abstract IA005: On the use of stem cells to generate sarcomas in vitro models

Judith V.M.G. Boveé
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (18_Supplement): IA005.
https://doi.org/10.1158/1557-3265.SARCOMAS22-IA005
Published: 15 September 2022
View article titled, Abstract IA005: On the use of stem cells to generate sarcomas in vitro models
Journal Articles

Comprehensive Molecular Analysis of Inflammatory Myofibroblastic Tumors Reveals Diverse Genomic Landscape and Potential Predictive Markers for Response to Crizotinib

Che-Jui Lee, Patrick Schöffski, Elodie Modave, Tom van Wezel, Bram Boeckx, Jozef Sufliarsky, Hans Gelderblom, Jean-Yves Blay, Maria Debiec-Rychter, Raf Sciot, Judith V.M.G. Bovée, Diether Lambrechts, Agnieszka Wozniak
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (24): 6737–6748.
https://doi.org/10.1158/1078-0432.CCR-21-1165
Published: 15 December 2021
View article titled, Comprehensive Molecular Analysis of Inflammatory Myofibroblastic Tumors Reveals Diverse Genomic Landscape and Potential Predictive Markers for Response to Crizotinib
Open the PDF for Comprehensive Molecular Analysis of Inflammatory Myofibroblastic Tumors Reveals Diverse Genomic Landscape and Potential Predictive Markers for Response to Crizotinib in another window
Includes: Supplementary data
Journal Articles

Telatinib Is an Effective Targeted Therapy for Pseudomyogenic Hemangioendothelioma

David G.P. van IJzendoorn, Stefan Sleijfer, Hans Gelderblom, Ferry A.L.M. Eskens, Geert J.L.H. van Leenders, Karoly Szuhai, Judith V.M.G. Bovée
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2018) 24 (11): 2678–2687.
https://doi.org/10.1158/1078-0432.CCR-17-3512
Published: 31 May 2018
View article titled, Telatinib Is an Effective Targeted Therapy for Pseudomyogenic Hemangioendothelioma
Open the PDF for Telatinib Is an Effective Targeted Therapy for Pseudomyogenic Hemangioendothelioma in another window
Includes: Supplementary data
Journal Articles

Functional Profiling of Receptor Tyrosine Kinases and Downstream Signaling in Human Chondrosarcomas Identifies Pathways for Rational Targeted Therapy

Yi-Xiang Zhang, Jolieke G. van Oosterwijk, Ewa Sicinska, Samuel Moss, Stephen P. Remillard, Tom van Wezel, Claudia Bühnemann, Andrew B. Hassan, George D. Demetri, Judith V.M.G. Bovée, Andrew J. Wagner
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2013) 19 (14): 3796–3807.
https://doi.org/10.1158/1078-0432.CCR-12-3647
Published: 15 July 2013
View article titled, Functional Profiling of Receptor Tyrosine Kinases and Downstream Signaling in Human Chondrosarcomas Identifies Pathways for Rational Targeted Therapy
Open the PDF for Functional Profiling of Receptor Tyrosine Kinases and Downstream Signaling in Human Chondrosarcomas Identifies Pathways for Rational Targeted Therapy in another window
Includes: Supplementary data